Insider · CIK 0001433982

ZELDIS JEROME B

Reports to the SEC for 10 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001433982

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−54 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−74 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−128 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−63 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−121 sh	—	—	0
2026-10-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−192 sh	—	—	0
2026-09-17	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+78.9K sh	—	—	78,947
2026-01-02	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	22,500
2026-01-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,475 sh	—	—	3,475
2025-06-25	NXGLNEXGEL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-06-20	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,647
2025-01-03	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	18,500
2025-01-03	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,800 sh	—	—	8,800
2024-12-12	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,646 sh	—	—	8,646
2024-12-02	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$51.00	+$612K	26,500
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−8,813 sh	$51.44	−$453K	17,687
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−3,187 sh	$52.42	−$167K	14,500
2024-12-02	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$30.86	+$370K	26,500
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−5,699 sh	$50.52	−$288K	20,801
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−2,634 sh	$51.43	−$135K	18,167
2024-12-02	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−3,667 sh	$52.39	−$192K	14,500
2024-12-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2024-12-02	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2024-11-20	NXGLNEXGEL, INC.P Purchase	Director	PPurchase	+3,636 sh	$2.75	+$9,999	106,664
2024-11-20	NXGLNEXGEL, INC. · Warrant to Purchase Common StockA Award	Director	AAward	+1,818 sh	—	—	1,818
2024-09-13	NXGLNEXGEL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-08-23	NXGLNEXGEL, INC.P Purchase	Director	PPurchase	+10K sh	$2.50	+$25K	103,028
2024-08-23	NXGLNEXGEL, INC. · Warrant to Purchase Common StockA Award	Director	AAward	+5,000 sh	—	—	5,000
2024-05-22	PTCTPTC THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$26.42	+$528K	34,500
2024-05-22	PTCTPTC THERAPEUTICS, INC.S Sale	Director	SSale	−20K sh	$38.24	−$765K	14,500
2024-05-22	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2024-02-15	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	14,500
2024-02-15	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-12-15	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+38.1K sh	—	—	38,136
2023-08-17	NXGLNEXGEL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-26	NXGLNEXGEL, INC.P Purchase	Director	PPurchase	+5,000 sh	$2.34	+$11.7K	93,028
2023-01-05	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+4,000 sh	—	—	10,500
2023-01-05	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-11-17	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+46.2K sh	—	—	145,285
2022-04-05	NexImmune, Inc.Stock Option (Right to Buy)A Award	Executive VP of Research & Dev	AAward	+80.1K sh	—	—	80,100
2022-03-25	NXGLNEXGEL, INC.P Purchase	Director	PPurchase	+5,300 sh	$1.89	+$10K	88,028
2022-01-07	PTCTPTC THERAPEUTICS, INC.A Award	Director	AAward	+3,200 sh	—	—	6,500
2022-01-07	PTCTPTC THERAPEUTICS, INC. · Stock Option (Right To Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-12-27	NXGLNEXGEL, INC.P Purchase	Director	PPurchase	+9,091 sh	$5.49	+$49.9K	82,728
2021-12-27	NXGLNEXGEL, INC. · Warrant to Purchase Common StockA Award	Director	AAward	+9,091 sh	$0.01	+$90.91	9,091
2021-09-23	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+29.1K sh	—	—	29,126
2021-05-14	SNGXSOLIGENIX, INC.P Purchase	Director	PPurchase	+3,000 sh	$0.89	+$2,664	25,917
2021-05-14	SNGXSOLIGENIX, INC.S Sale	Director	SSale	−3,000 sh	$0.90	−$2,700.6	22,917
2021-03-08	NXGLNEXGEL, INC. · Option to Purchase Common StockA Award	Director	AAward	+667K sh	—	—	666,667
2021-02-17	NexImmune, Inc.P Purchase	Executive VP of Research & Dev	PPurchase	+5,882 sh	$17.00	+$100K	5,882

Recent filings

Accepted (ET)
Oct 134
ZELDIS JEROME B0001433982-26-000006
SEC(opens sec.gov)
Sep 184
ZELDIS JEROME B0001433982-26-000004
SEC(opens sec.gov)
Jan 64
ZELDIS JEROME B0001433982-26-000002
SEC(opens sec.gov)
Jun 274
ZELDIS JEROME B0001641172-25-016991
SEC(opens sec.gov)
Jun 204
ZELDIS JEROME B0001415889-25-017860
SEC(opens sec.gov)
Jan 74
ZELDIS JEROME B0001415889-25-001030
SEC(opens sec.gov)
Dec 134
ZELDIS JEROME B0001415889-24-029298
SEC(opens sec.gov)
Dec 44
ZELDIS JEROME B0001415889-24-028287
SEC(opens sec.gov)

Companies

Address

C/O SOLIGENIX, INC. 29 EMMONS DRIVE, SUITE B-10

PRINCETON, NJ, 08540